Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma

Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma

Saved in:

Bibliographic Details
Main Authors:	Elizabeth K. O’Donnell, Jennifer E. Carroll, Jaqueline Perry, Katherine Padgett, Benjamin Harris, Vidhi Patel, Omar Nadeem, Areej El-Jawahri, Irene M. Ghobrial, Catherine R. Marinac
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Blood Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952925000692
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA?
by: Ugo Testa, et al.
Published: (2024-04-01)

The role of bone marrow microenvironment in the progression of multiple myeloma from monoclonal gammopathy of undetermined significance
by: A. S. Khudovekova, et al.
Published: (2021-09-01)

Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
by: Melissa A. Lyle, et al.
Published: (2022-01-01)

Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
by: Anping Xu, et al.
Published: (2024-12-01)

Screening for monoclonal gammopathies of undetermined significance: A prospective study
by: Aissam El Maataoui, et al.
Published: (2025-03-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Prognostic Value of Hepatocyte Growth Factor, Syndecan-1, and Osteopontin in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
by: Jiri Minarik, et al.
Published: (2012-01-01)

Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population‐based screening study
by: Sæmundur Rögnvaldsson, et al.
Published: (2024-11-01)

The specific transcriptional profile and clonal selection of monoclonal gammopathy of undetermined significance-like behavior predict an exceptionally favorable prognosis in multiple myeloma
by: Wenqiang Yan, et al.
Published: (2025-04-01)

Multiparameter flow cytometric and transcriptional analyis of CD20 positive T-cells in bone marrow in patients of multiple myeloma and monoclonal gammopathy of undetermined significance
by: Barbara Forró, et al.
Published: (2025-02-01)

Monoclonal gammopathy of undetermined significance with associated necrotizing myopathy: a case report and review of the literature
by: Anna Bode, et al.
Published: (2025-04-01)

Sarcoidosis and Monoclonal Gammopathy of Undetermined Significance (MGUS): A True Association or Just a Coincidence?
by: Mohamed Hassanein, et al.
Published: (2018-01-01)

PARAPROTEINEMIC POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: СLINICAL CASE DESCRIPTION AND LITERATURE REVIEW
by: A. A. Yakovlev, et al.
Published: (2017-09-01)

Case Report: IgG4-RD-related ophthalmopathy combined with monoclonal gammopathy of undetermined significance
by: Shanshan Liang, et al.
Published: (2025-05-01)

Successful Daratumumab, Lenalidomide, and Dexamethasone Treatment of Refractory Type I Cryoglobulinemia From Monoclonal Gammopathy of Undetermined Significance
by: Karen J. Shou, et al.
Published: (2024-11-01)

Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapy
by: Alba Rodríguez-García, et al.
Published: (2025-02-01)

Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis
by: Cecilie Velsoe Maeng, et al.
Published: (2025-04-01)

Synovitis, acne, pustular lesions, hyperostosis, and osteitis syndrome associated with monoclonal gammopathy of undetermined significance: a case report
by: Cheng Xu, et al.
Published: (2025-07-01)

Successful Treatment of Concomitant Pleural Mucosa-Associated Lymphoid Tissue Lymphoma and Monoclonal Gammopathy of Undetermined Significance with Lenalidomide, Rituximab, and Dexamethasone
by: Yoshiki Uemura, et al.
Published: (2022-01-01)

Correction: Revised free light chain reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance and reduce overdiagnosis
by: Cecilie Velsoe Maeng, et al.
Published: (2025-05-01)

Assessing the performance of the Iceland screens, treats, or prevents multiple myeloma (iStopMM) model in a multicultural Bronx cohort: implications for monoclonal gammopathy of undetermined significance risk stratification
by: Rajvi Gor, et al.
Published: (2025-08-01)

Plasma cell dyscrasia: monoclonal gammopathies, AL-amyloidosis, multiple myeloma Clinical case study
by: V. V. Cherepanova, et al.
Published: (2023-03-01)

Patient preferences for intervention in the setting of precursor multiple myeloma
by: Catherine R. Marinac, et al.
Published: (2024-10-01)

Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case
by: Sassine Ghanem, et al.
Published: (2016-01-01)

Unusual Cases of Monoclonal Gammopathy of Renal Significance
by: Anjellica Chen, et al.
Published: (2024-01-01)

WCN25-4500 INCIDENCE AND RISK FACTORS FOR MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS) IN PATIENTS WITH MONOCLONAL GAMMOPATHY AND RENAL DISEASE
by: Henrique Borges, et al.
Published: (2025-02-01)

Mutational Landscape of Bone Marrow CD19 and CD138 Cells in Waldenström Macroglobulinemia (WM) and IgM Monoclonal Gammopathy of Undetermined Significance (IgM MGUS)
by: Alessandra Trojani, et al.
Published: (2024-12-01)

Successful Management of Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance After Sotorasib Treatment in a Patient with Non-Small-Cell Lung Carcinoma
by: Mélissa Julien, et al.
Published: (2025-04-01)

Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
by: Jakub Radocha, et al.
Published: (2018-08-01)

Monoclonal gammopathy of renal significance: From bench to bedside
by: Megha Saigal, et al.
Published: (2025-01-01)

Monoclonal gammopathy in WHIM syndrome can mask hypogammaglobulinemia
by: Julia Lew, MD, et al.
Published: (2025-08-01)

Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance
by: Holly Lee, et al.
Published: (2019-01-01)

Advancements in the Treatment of High-Risk Smoldering Myeloma: News from ASH 2024
by: Kaveh Samii
Published: (2024-12-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

Transient Monoclonal Gammopathy Induced by Disseminated Staphylococcus aureus Infection
by: Dimitrios Stoimenis, et al.
Published: (2012-01-01)

Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML
by: Bita Fakhri, et al.
Published: (2017-01-01)

The experience of free light chains of immunoglobulin elimination in patients with monoclonal gammopathies
by: E. G. Gromova, et al.
Published: (2019-07-01)

Diagnostic and Therapeutic Aspects of Monoclonal Gammopathies of Renal Significance (MGRS): An Update
by: Giuseppe Stefano Netti, et al.
Published: (2024-12-01)

Clinical features of monoclonal gammopathy of renal significance related renal lesions
by: Xiao-jing Wu, et al.
Published: (2022-08-01)

Generalized Acquired Cutis Laxa Associated with Monoclonal Gammopathy of Dermatological Significance
by: Sophia Z. Shalhout, et al.
Published: (2020-01-01)